IDB Lab Research
Investment Thesis
IDB Lab is the innovation and venture arm of the Inter-American Development Bank (IDB) Group, the largest source of development financing for Latin America and the Caribbean (LAC). Rather than operating as a traditional for-profit fund, IDB Lab deploys grants, equity, quasi-equity, and debt to mobilize entrepreneurial innovation and disruptive technology toward two intertwined goals: benefiting vulnerable and underserved populations and activating sustainable, high-growth industries across the region. IDB Lab's current strategy (2025-2027 Business Plan) organizes its work around three thematic priorities: climate and environmental resilience, access to quality essential services (financial, health, and education), and expanding livelihood opportunities. It also runs several flagship initiatives, including WeXchange (female entrepreneurship in STEM), fAIr LAC (responsible AI adoption), CIVLAC (corporate social venturing), and programs targeting the Silver Economy and Amazon biodiversity-based businesses.
Stage Focus
IDB Lab invests across the full early-stage spectrum, from pre-seed through Series B, and also backs venture capital funds targeting pre-seed through Series B companies. Its direct equity/quasi-equity strategy has a dedicated seed track for "C&D" (nascent/emerging) ecosystems in the region, while its debt product targets post-Series A companies with over $1M in revenue.
Check Size
IDB Lab operates several distinct financing instruments with different ticket sizes:
- Venture capital fund commitments: $2M-$10M (minimum fund size $20M, or $10M for nascent ecosystems)
- Direct equity/quasi-equity: $200K-$500K at seed, $1M-$3M at Series A/B
- Debt / venture debt: $500K-$5M, 3-7 year terms (avg. 5 years), up to 24-month grace period
- Ecosystem-building projects: $750K-$2M
- Smallest instruments can go as low as $150K
Lead Tendency
IDB Lab generally does not lead priced equity rounds. Its equity and quasi-equity product explicitly requires "strong co-investment participation from qualified institutional investors," and most of its recent direct investments (Aviva, Sofía, ISA Saúde) were structured as participations alongside other lead investors (Index Ventures, Kaszek, K Fund, IFC, Dalus Capital, Endeavor Catalyst). It is more often the anchor or cornerstone LP when investing into venture capital funds (e.g., 500 LatAm, Amador Seed Fund II).
Recent Activity
IDB Lab remains one of the most active LP/investors in LAC venture capital, having backed over 90 funds since 1996 with a current portfolio of 50+ active funds and roughly 850 underlying portfolio companies. Its direct equity book has 23 active investments, 60% with women co-founders. Recent activity (late 2025-2026):
- December 2025: Up to $3M into Amador Seed Fund II (Panama/Mexico-based, Central America focus)
- 2025-2026: $1.5M venture-debt investment in Aviva (Mexico, AI-powered credit kiosks) - IDB Lab's first venture-debt operation in LAC
- September 2025: $2M into 500 LatAm Seed Fund IV, targeting ~40 startups in emerging ecosystems (Costa Rica, Dominican Republic, Ecuador, Guatemala, Peru, Uruguay)
- October 2025: Participated in ISA Saúde's $30M Series B (Brazil, hospital-at-home), led by IFC
- Ongoing: Annual Call for Proposals for new VC fund commitments (2026 call closes September 30, 2026, for 2027 vintage)
Portfolio Highlights
Notable direct/co-investments include Sempli (Colombia, SME digital lending), EthicHub (agricultural crowdlending, blockchain-based), Ayenda (Colombia/Mexico/Peru budget hotel chain), Cubo (El Salvador, digital payments for micro-merchants), ZoomAgri (Spain/global, AI grain-quality inspection), Aviva (Mexico, AI credit kiosks), Sofía (Mexico, digital health insurance), and ISA Saúde (Brazil, hospital-at-home care). VIRNECT is a notable fund-level exit (IPO, 2023).
Team
- Graham Macmillan - CEO / General Manager, IDB Lab
- Magdalena Coronel - Chief Investment Officer
- César Buenadicha - Head, Ecosystem Building and Acceleration Division
- Laura Vélez - Chief of Finance and Administration (CFO/CRO)
- Yuri Soares - Principal Impact Officer
Decision Process
As a multilateral development institution, IDB Lab operates through structured investment/project approval processes (project profiles, due diligence, and internal committee approval) rather than a solo GP or small partnership vote - closer to an investment committee model, with governance tied to the Agreement Establishing the Multilateral Investment Fund IV.
Founder Preferences
IDB Lab favors founders building scalable, tech-enabled solutions with clear impact on underserved or vulnerable populations - financial inclusion, health access, climate resilience, and livelihood generation - particularly in "C&D" (nascent/emerging) LAC ecosystems and with meaningful gender diversity on founding/leadership teams.
Geographic Focus
Latin America and the Caribbean broadly, with explicit emphasis on emerging ecosystems (Central America, Costa Rica, Dominican Republic, Ecuador, Guatemala, Peru, Uruguay) alongside larger markets (Mexico, Colombia, Brazil).